|
The race is on around the world to find a vaccine that will stop COVID-19 in its tracks. One of the trials involves South Africa, Brazil and the UK. Professor Shabir Madhi is leading the South African leg of the trial. In this article he answers questions about how it will be run, why Africa’s involvement is so important, what’s at stake and what people’s expectations should be.
You can also listen to his answers in this podcast.
|
A general view during the country’s first human clinical trial for a potential COVID-19 vaccine in Soweto, South Africa.
Felix Dlangamandla/Beeld/Gallo Images via Getty Images
Shabir Madhi, University of the Witwatersrand
There isn't enough clinical research being done in Africa. This has had a lot of repercussions in terms of the timing when interventions become available and effective in high income countries.
|
shutterstock.
Ozayr Patel, The Conversation
South Africa is trialling a vaccine for COVID-19. Here's what you need to know about it.
|
Health + Medicine
|
Michael Zandi, UCL
The virus seems to have a range of effects on the brain, even in patients with only mild lung illness.
| |
Keith Grehan, University of Leeds
Do bats hold the secret to defeating coronaviruses?
|
|
|
Business + Economy
|
David L. Di Maria, University of Maryland, Baltimore County
A new immigration rule may force some international students to leave the country.
| |
John Whittaker, Lancaster University
Creating lots of new money is supposed to produce runaway inflation. The longer that it doesn't happen, the more this branch of economics appears to have a point.
|
Cory Maks-Solomon, George Washington University
Big businesses often engage in social activism because they want to sway public policy outcomes. They’re not exclusively trying to appeal to liberal customers.
| |
Komali Kantamaneni, Solent University; Komali Yenneti, University of Melbourne; Louis Rice, University of the West of England; Luiza C Campos, UCL
Climate shocks and changing weather mean that farmers' incomes are
|
|
|
